The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs
JBIC Journal of Biological Inorganic Chemistry · 24.04.2026 · 31 (3) · 103-117
DOI: 10.1007/s00775-026-02143-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, online erschienen am 24.04.2026. Verfasst von Hongyan Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, the University of Hong Kong, SAR, Pokfulam Road, Hong Kong, P.R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Proteome, Neoplasms, Arsenicals. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council, University Grants Committee.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, the University of Hong Kong, SAR, Pokfulam Road, Hong Kong, P.R. China.
- Department of Chemistry, the University of Hong Kong, SAR, Pokfulam Road, Hong Kong, P.R. China. hylichem@hku.hk.
Förderung
- Research Grants Council, University Grants Committee
Zitieren
APA
Li, H., & Sun, H. (2026). The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs. JBIC Journal of Biological Inorganic Chemistry, 31(3), 103-117. https://doi.org/10.1007/s00775-026-02143-2
Vancouver
Li H, Sun H. The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs. JBIC Journal of Biological Inorganic Chemistry. 2026;31(3):103-117. doi:10.1007/s00775-026-02143-2
BibTeX
@article{Li2026,
author = {Li, Hongyan and Sun, Hongzhe},
title = {The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs},
journal = {JBIC Journal of Biological Inorganic Chemistry},
year = {2026},
volume = {31},
number = {3},
pages = {103--117},
doi = {10.1007/s00775-026-02143-2}
}
EUVIMED